Katopodi, T.; Petanidis, S.; Grigoriadou, E.; Anestakis, D.; Charalampidis, C.; Chatziprodromidou, I.; Floros, G.; Eskitzis, P.; Zarogoulidis, P.; Koulouris, C.;
et al. Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy. Pharmaceutics 2024, 16, 455.
https://doi.org/10.3390/pharmaceutics16040455
AMA Style
Katopodi T, Petanidis S, Grigoriadou E, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C,
et al. Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy. Pharmaceutics. 2024; 16(4):455.
https://doi.org/10.3390/pharmaceutics16040455
Chicago/Turabian Style
Katopodi, Theodora, Savvas Petanidis, Eirini Grigoriadou, Doxakis Anestakis, Charalampos Charalampidis, Ioanna Chatziprodromidou, George Floros, Panagiotis Eskitzis, Paul Zarogoulidis, Charilaos Koulouris,
and et al. 2024. "Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy" Pharmaceutics 16, no. 4: 455.
https://doi.org/10.3390/pharmaceutics16040455
APA Style
Katopodi, T., Petanidis, S., Grigoriadou, E., Anestakis, D., Charalampidis, C., Chatziprodromidou, I., Floros, G., Eskitzis, P., Zarogoulidis, P., Koulouris, C., Sevva, C., Papadopoulos, K., Roulia, P., Mantalovas, S., Dagher, M., Karakousis, A. V., Varsamis, N., Vlassopoulos, K., Theodorou, V.,
... Kosmidis, C.
(2024). Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy. Pharmaceutics, 16(4), 455.
https://doi.org/10.3390/pharmaceutics16040455
